N6-methyladenosine–mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B/let-7/MYCN signaling
JCI Insight · 2023
DOI: 10.1172/jci.insight.165703 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2023. Verfasst von Yun Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's C…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neuroblastoma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the National Key R&D Program of China.
Abstract (Originalsprache)
Neuroblastomas have shed light on the differentiation disorder that is associated with spontaneous regression or differentiation in the same tumor at the same time. Long noncoding RNAs (lncRNAs) actively participate in a broad spectrum of biological processes. However, the detailed molecular mechanisms underlying lncRNA regulation of differentiation in neuroblastomas remain largely unknown. Here, we sequenced clinical samples of ganglioneuroma, ganglioneuroblastoma, and neuroblastoma. We compared transcription profiles of neuroblastoma cells, ganglion cells, and intermediate state cells; verified the profiles in a retinoic acid–induced cell differentiation model and clinical samples; and screened out the lncRNA ADAMTS9 antisense RNA 2 ( ADAMTS9-AS2 ), which contributed to neuroblastoma differentiation. ADAMTS9-AS2 upregulation in neuroblastoma cell lines inhibited proliferation and metastatic potential. Additional mechanistic studies illustrated that the interactions between ADAMTS9-AS2 and LIN28B inhibited the association between LIN28B and primary let-7 ( pri-let-7 ) miRNA, then released pri-let-7 into cytoplasm to form mature let-7 , resulting in the inhibition of oncogene MYCN activity that subsequently affected cancer stemness and differentiation. Furthermore, we showed that the observed differential expression of ADAMTS9-AS2 in neuroblastoma cells was due to N 6 -methyladenosine methylation. Finally, ADAMTS9-AS2 upregulation inhibited proliferation and cancer stem-like capabilities in vivo. Taken together, these results show that ADAMTS9-AS2 loss leads to malignant neuroblastoma by increasing metastasis and causing dysfunctional differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Preventio…
- Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
- Department of Thoracic Surgery, The Second Hospital of Tianjin Medical University, Tianjin, China.
Förderung
- the National Natural Science Foundation of China
- the National Key R&D Program of China
Zitieren
APA
Liu, Y., Zhang, J., Cao, F., Dong, X., Li, J., Cao, Y., Li, Z., Guo, Y., Yan, J., Liu, Y., & Zhao, Q. (2023). N6-methyladenosine–mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B/let-7/MYCN signaling. JCI Insight. https://doi.org/10.1172/jci.insight.165703
Vancouver
Liu Y, Zhang J, Cao F, Dong X, Li J, Cao Y, et al. N6-methyladenosine–mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B/let-7/MYCN signaling. JCI Insight. 2023. doi:10.1172/jci.insight.165703
BibTeX
@article{Liu2023,
author = {Liu, Yun and Zhang, Jun and Cao, Fang and Dong, Xiaobao and Li, Jie and Cao, Yanna and Li, Zhanglin and Guo, Yan and Yan, Jie and Liu, Yuanyuan and Zhao, Qiang},
title = {N6-methyladenosine–mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B/let-7/MYCN signaling},
journal = {JCI Insight},
year = {2023},
doi = {10.1172/jci.insight.165703}
}
EUVIMED